Phase II trial of iproplatin in advanced squamous cell carcinoma of the head and neck, oesophagus and lung
- 31 December 1993
- journal article
- other
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (8), 1216
- https://doi.org/10.1016/s0959-8049(05)80327-2
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIPCancer Chemotherapy and Pharmacology, 1990
- Phase II Study of Iproplatin (CHIP) in Previously Treated Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1989
- Randomized Phase II Evaluation of Iproplatin (CHIP) and Carboplatin (CBDCA) in Lung CancerAmerican Journal of Clinical Oncology, 1988
- Iproplatin and carboplatin induced toxicities: Overview of phase II clinical trial conducted by the EORTC early clinical trials cooperative group (ECTG)European Journal of Cancer and Clinical Oncology, 1988
- Phase II study of iproplatin (CHIP, JM-9) in advanced squamous cell carcinoma of the head and neckEuropean Journal of Cancer and Clinical Oncology, 1987